Skip to content

A clinical trial to study the effect of exercises to improve quality of life in patients with COPD.

Comparison of the effects of upper limb endurance and strength training on pulmonary functions, dyspnea, health related quality of life and functional outcomes in patients with COPD.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053130
Enrollment
100
Registered
2023-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Endurance training: COPD patients will be given upper limb endurance training during pulmonary rehabilitation program for 4 weeks. Intervention2: Strength training: COPD patients will b

Sponsors

Pt B D Sharma PGIMS Rohtak Haryana India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men and women diagnosed with COPD according to GOLD criteria above the age of 40 years old will be recruited from OPD of Pt. B.D.S. PGIMS Rohtak. 2. COPD stages from 2 to 4 (A-D) diagnosed according to GOLD criteria. 3. FEV1/FVC 4. Subjects undergoing stable respiratory medication with no exacerbations. 5. Patients willing to participate and given informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with acute exacerbation. 2. Have severe cognitive or psychotic impairment. 3. Musculoskeletal or neurological conditions that prevent exercise. 4. Unstable cardiovascular disease (e.g., unstable angina, aortic valve disease, unstable pulmonary hypertension). 5. Patients requiring oxygen supplementation during exercise. 6. Patients with incapacity to follow a standard rehabilitation program. 7. Patients with shoulder pain, shoulder osteoarthritis, or shoulder surgery. 8. Rib fracture or a relevant infectious disease. 9. Pregnant or breastfeeding women. 10. H/O pneumonectomy or lobectomy in past 6month 11. Non-cooperative patients or patients under tutorship or curatorship. 12. Suffering from another disease like pulmonary hypertension or lung cancer. 13. Uncontrolled comorbidity on physician discretion.

Design outcomes

Primary

MeasureTime frame
1. Pulmonary functions- Forced Expiratory Volume in 1 second (FEV1) Forced Vital Capacity (FVC) FEV1/FVC 2. Dyspnoea- Modified Borgâ??s scale (Hindi version)Timepoint: Baseline readings will be taken prior to intervention at 1st week of intervention and then same parameters on end of 4th week and on 8th week of intervention on follow up.

Secondary

MeasureTime frame
1. Quality of life and dyspnoea associated with activities of daily living assessment -SGRQ Hindi version -COPD assessment test score CAT Hindi version 2. Psychological status assessment â?? anxiety and depression scale DASS 21-Hindi 3. Functional outcomes- â?¢ 6MWT â?¢ Arm activity levels 4. Dyspnoea will be assessed after 6MWT Time to complete an activity (Glittre ADLâ??S test, PNF pattern D1-D2 with 0.5kg of weight, Grocery shelving task and Blackboard erasing taskTimepoint: Baseline readings will be taken prior to intervention at 1st week of intervention and then same parameters on end of 4th week and on 8th week of intervention on follow up.

Countries

India

Contacts

Public ContactDr Pawan Singh

college of physiotherapy, Pt. B. D. Sharma University of health sciences, PGIMS, Rohtak

gsikka.cphy@uhsr.ac.in7027192620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026